Last reviewed · How we verify
Acute gonococcal urethritis
Approved treatments
- MEZLOCILLIN
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Doxycyclin · Bulovka Hospital
- Unasyn · Bristol-Myers Squibb
- Abelcet · Astellas Pharma
- Ceftin · GSK
Ceftin works by inhibiting the bacterial enzyme responsible for cell wall synthesis, ultimately leading to bacterial cell death. - Demethylchlortetracycline · Pfizer
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - E-Mycin · Generic (originally Abbott/Lilly)
- Ciprofloxacine · Poitiers University Hospital
- ALATROFLOXACIN · Pfizer
- Meclan · Johnson And Johnson
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Zithromax · Pfizer Inc.
Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life. - Zymar · Allergan
- Benzamycin · Pfizer
- Vantin
- Enoksetin
- Zinacef · GSK
Zinacef works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Noroxin
- Floxin
- Epocelin
- Minocycline Hydrochloride · Rempex
MINOCYCLINE works by inhibiting protein synthesis in bacteria, ultimately leading to their death. - Cipro · Bayer AG
- Vibramycin · Generic (originally Pfizer)
- Suprax
Suprax works by inhibiting the bacterial enzyme 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, disrupting bacterial cell wall synthesis. - Rocephin · Generic (originally Roche)
- SPECT · Tomsk National Research Medical Center of the Russian Academy of Sciences
Spect works by interacting with a specific biological target to produce a therapeutic effect. - ENOXA® · Les Laboratoires des Médicaments Stériles
Enoxa is a small molecule drug, but its exact mechanism of action is unknown. - Ofloxacine · Assistance Publique - Hôpitaux de Paris
- Minocyclin · University of Southern California
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute gonococcal urethritis patent landscape — cliff calendar, originator estates, attackable patents
- Acute gonococcal urethritis treatment landscape brief
- Acute gonococcal urethritis treatment updates RSS
Frequently asked questions about Acute gonococcal urethritis
What drugs treat Acute gonococcal urethritis?
Tracked treatments include MEZLOCILLIN, Ramycin, Doxycyclin, Unasyn, Abelcet, Ceftin, Demethylchlortetracycline, Pipracil.
What is the treatment for Acute gonococcal urethritis?
Standard treatment for Acute gonococcal urethritis includes MEZLOCILLIN, Ramycin, Doxycyclin, Unasyn, Abelcet. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acute gonococcal urethritis patent cliff · Acute gonococcal urethritis CI report
- Treatment: MEZLOCILLIN
- Treatment: Ramycin
- Treatment: Doxycyclin · Bulovka Hospital
- Treatment: Unasyn · Bristol-Myers Squibb
- Treatment: Abelcet · Astellas Pharma
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing